February 19, 1997
VIA ELECTRONIC TRANSMISSION
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Re: Amendment to Schedule 13G
Ladies and Gentlemen:
Submitted herewith is Amendment No. 6 to the Schedule 13G for Fred P.
Lampropoulos. This filing is being effected by direct transmission via the
Commission's EDGAR System. No fee is required in connection with this filing. If
you have any questions concerning this material, please do not hesitate to call
the undersigned or Richard G. Brown at (801) 532-7840.
Sincerely,
/s/ SUSAN ALLEN
Susan Allen
Legal Assistant
Attachment
cc: Merit Medical Systems, Inc.
richard G. Brown
c:\wp51\secfil\sos\sec-ltr7.ska
1
<PAGE>
OMB APPROVAL
OMB Number 3235-0145
Expires: December 31, 1997
Estimated average burden
hours per response.......14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 6 )*
Merit Medical Systems, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, No Par Value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
589889-10-4
-------------------------------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SEC 1745 (2-95)
Page 1 of 4 Pages
<PAGE>
CUSIP No. 589889-10-4 Page 2 of 4 Pages
13G
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Fred P. Lampropoulos
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF 630,618
SHARES ----------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH None
REPORTING ----------------------------------------------------
PERSON 7 SOLE DISPOSITIVE POWER
WITH
630,618
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
None
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
630,618
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.0%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
SEC 1745 (2-95)
<PAGE>
CUSIP NO. 589889-10-4 Page 3 of 4 Pages
13G
Item 1.
(a) Name of Issuer: Merit Medical Systems, Inc.
(b) Address of Issuer's Principal Executive Offices: 1600 West
Merit Parkway, South Jordan, Utah 84095
Item 2.
(a) Name of Person Filing: Fred P. Lampropoulos (the "Reporting
Person")
(b) Address of Principal Business Office or, if none, Residence:
1600 West Merit Parkway, South Jordan, Utah 84095
(c) Citizenship: United States
(d) Title of Class of Securities: Common Stock, no par value (the
"Common Stock")
(e) CUSIP Number: 589889-10-4
Item 3.
This statement is not filed pursuant to Rule 13d-1(b) or
13d-2(b).
Item 4. Ownership
(a) Amount Beneficially Owned: As of December 31, 1996 the
Reporting Person was the owner of 630,618 shares of the Common
Stock, which includes 9,036 shares owned by the Reporting
Person pursuant to the Issuer's 401(k) Plan, based upon the
most recent plan statement timely distributed, and 51,500
shares that the Reporting Person has the right to acquire
pursuant to presently exercisable options.
(b) Percent of Class: 9.0%
(c) Number of shares as to which the Reporting Person has:
(i) sole power to vote or to direct the vote: 630,618
(ii) shared power to vote or to direct the vote: None
(iii) sole power to dispose or to direct the disposition
of: 630,618
(iv) shared power to dispose or to direct the disposition
of: None
SEC 1745 (2-95)
<PAGE>
CUSIP NO. 589889-10-4 Page 4 of 4 Pages
13G
Item 5. Ownership of Five Percent or Less of a Class
This statement is not being filed to report the fact that as
of the date hereof the Reporting Person has ceased to be the beneficial
owner of more than five percent of the class of securities.
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company
Not applicable.
Item 8. Identification and Classification of Members of the Group
Not applicable.
Item 9. Notice of Dissolution of Group
Not applicable.
Item 10. Certification
Not applicable.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
DATED: February 18, 1997
By /s/ FRED P. LAMPROPOULOS
------------------------
Fred P. Lampropoulos
SEC 1745 (2-95)
